-
EP4308077
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4308077
| EP4308077 - LONG ACTING INJECTABLE FORMULATION COMPRISING RISPERIDONE AND BIODEGRADABLE POLYMERS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 22.12.2023 Database last updated on 08.10.2024 | |
| Former | The international publication has been made Status updated on 23.09.2022 | ||
| Former | unknown Status updated on 22.04.2022 | Most recent event Tooltip | 24.05.2024 | Change: Validation states | published on 26.06.2024 [2024/26] | 24.05.2024 | Change - extension states | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states MedinCell S.A. 3 rue des frères Lumière 34830 Jacou / FR | [2024/04] | Inventor(s) | 01 /
MERENLENDER WAGNER, Avia 3056009 Binyamina / IL | 02 /
ELGART VALITSKY, Anna 4420702 Kfar-Saba / IL | 03 /
HARARY, Eran 42504 Netanya / IL | [2024/04] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
| Former [2024/04] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 22716046.2 | 17.03.2022 | [2024/04] | WO2022EP57009 | Priority number, date | WO2021IB52248 | 17.03.2021 Original published format: PCT/IB2021/052248 | US202163162272P | 17.03.2021 Original published format: US 202163162272 P | US202163208860P | 09.06.2021 Original published format: US 202163208860 P | US202163270174P | 21.10.2021 Original published format: US 202163270174 P | [2024/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022195018 | Date: | 22.09.2022 | Language: | EN | [2022/38] | Type: | A1 Application with search report | No.: | EP4308077 | Date: | 24.01.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.09.2022 takes the place of the publication of the European patent application. | [2024/04] | Search report(s) | International search report - published on: | EP | 22.09.2022 | Classification | IPC: | A61K9/00, A61K31/519, A61K47/34, A61P25/18 | [2024/04] | CPC: |
A61K9/0019 (EP,IL,KR,US);
A61K31/519 (EP,IL,KR,US);
A61K47/10 (US);
A61K47/34 (EP,IL,KR,US);
A61P25/18 (EP,IL,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/04] | Title | German: | LANGWIRKENDE INJIZIERBARE FORMULIERUNG MIT RISPERIDON UND BIOLOGISCH ABBAUBAREN POLYMEREN | [2024/04] | English: | LONG ACTING INJECTABLE FORMULATION COMPRISING RISPERIDONE AND BIODEGRADABLE POLYMERS | [2024/04] | French: | FORMULATION INJECTABLE À ACTION PROLONGÉE COMPRENANT DE LA RISPÉRIDONE ET DES POLYMÈRES BIODÉGRADABLES | [2024/04] | Entry into regional phase | 05.10.2023 | National basic fee paid | 05.10.2023 | Designation fee(s) paid | 05.10.2023 | Examination fee paid | Examination procedure | 05.10.2023 | Examination requested [2024/04] | 05.10.2023 | Date on which the examining division has become responsible | 17.04.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 07.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2019099495 (GAUDRIAULT GEORGES [FR]); | [Y]US2021038724 (GAUDRIAULT GEORGES [FR]); | [IP]WO2021048817 (MEDINCELL S A [FR]); | by applicant | US9023897 | US2019160171 |